Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Analytical Approaches in Human Sports Drug Testing - Recent Advances, Challenges, and Solutions.

Thevis M, Walpurgis K, Thomas A.

Anal Chem. 2019 Oct 14. doi: 10.1021/acs.analchem.9b04639. [Epub ahead of print]

PMID:
31610649
2.

Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine.

Lehmann S, Sczyslo A, Froch-Cortis J, Rothschild MA, Thevis M, Andresen-Streichert H, Mercer-Chalmers-Bender K.

Forensic Sci Int. 2019 Sep 12;303:109959. doi: 10.1016/j.forsciint.2019.109959. [Epub ahead of print]

PMID:
31546164
3.

Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).

Lehmann S, Thomas A, Schiwy-Bochat KH, Geyer H, Thevis M, Glenewinkel F, Rothschild MA, Andresen-Streichert H, Juebner M.

Forensic Sci Int. 2019 Aug 8;303:109925. doi: 10.1016/j.forsciint.2019.109925. [Epub ahead of print]

PMID:
31499423
4.

Implementation and Performance of the Gas Chromatography/Combustion/Isotope Ratio Mass Spectrometry-Based Method for the Confirmatory Analysis of Endogenous Anabolic Steroids during the Rio de Janeiro Olympic and Paralympic Games 2016.

de Oliveira FA, Casilli A, Piper T, da Silva TR, da Silva CA, da Silva RVS, Dal Sasso MA, Salgueiro GRDSG, Padilha MC, Pereira HMG, Thevis M, de Aquino Neto FR.

Anal Chem. 2019 Sep 17;91(18):11747-11756. doi: 10.1021/acs.analchem.9b02341. Epub 2019 Aug 29.

PMID:
31423767
5.

Effect of Acute and Chronic Xenon Inhalation on Erythropoietin, Hematological Parameters, and Athletic Performance.

Dias KA, Lawley JS, Gatterer H, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Shuo-Wen Liang A, Hendrix M, Piper T, Thevis M, Bruick RK, Levine BD.

J Appl Physiol (1985). 2019 Aug 15. doi: 10.1152/japplphysiol.00289.2019. [Epub ahead of print]

PMID:
31414957
6.

Safety, hemodynamic effects and detection of acute xenon inhalation: Rationale for banning xenon from sport.

Lawley JS, Gatterer H, Dias KA, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Hendrix M, Piper T, Thevis M, Levine BD.

J Appl Physiol (1985). 2019 Aug 15. doi: 10.1152/japplphysiol.00290.2019. [Epub ahead of print]

PMID:
31414955
7.

Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.

Gaunitz F, Kieliba T, Thevis M, Mercer-Chalmers-Bender K.

Drug Test Anal. 2019 Aug 14. doi: 10.1002/dta.2680. [Epub ahead of print]

PMID:
31412168
8.

Development of two complementary LC-HRMS methods for analyzing sotatercept in dried blood spots for doping controls.

Lange T, Walpurgis K, Thomas A, Geyer H, Thevis M.

Bioanalysis. 2019 May;11(10):923-940. doi: 10.4155/bio-2018-0313.

PMID:
31218901
9.

In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.

Gaunitz F, Dahm P, Mogler L, Thomas A, Thevis M, Mercer-Chalmers-Bender K.

Anal Bioanal Chem. 2019 Jun;411(16):3561-3579. doi: 10.1007/s00216-019-01837-8. Epub 2019 Jun 10.

PMID:
31183523
10.

Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency.

Hammels I, Binczek E, Schmidt-Soltau I, Jenke B, Thomas A, Vogel M, Thevis M, Filipova D, Papadopoulos S, Stoffel W.

J Lipid Res. 2019 Aug;60(8):1396-1409. doi: 10.1194/jlr.M094664. Epub 2019 Jun 5.

11.

Differing Water Intake and Hydration Status in Three European Countries-A Day-to-Day Analysis.

Braun H, von Andrian-Werburg J, Malisova O, Athanasatou A, Kapsokefalou M, Ortega JF, Mora-Rodriguez R, Thevis M.

Nutrients. 2019 Apr 3;11(4). pii: E773. doi: 10.3390/nu11040773.

12.

Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane?

Garzinsky AM, Walpurgis K, Krug O, Thevis M.

Drug Test Anal. 2019 Mar 29. doi: 10.1002/dta.2597. [Epub ahead of print]

PMID:
30927335
13.

Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation.

Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M, Mercer-Chalmers-Bender K.

Int J Legal Med. 2019 Jul;133(4):1049-1064. doi: 10.1007/s00414-018-1964-8. Epub 2018 Dec 18.

PMID:
30564916
14.

Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.

Gaunitz F, Lehmann S, Thomas A, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K.

Int J Legal Med. 2019 May;133(3):973. doi: 10.1007/s00414-018-1976-4.

PMID:
30515589
15.

Annual banned-substance review: Analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H.

Drug Test Anal. 2019 Jan;11(1):8-26. doi: 10.1002/dta.2549. Epub 2019 Jan 6. Review.

PMID:
30488582
16.

SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins.

Reichel C, Gmeiner G, Reihlen P, Thevis M, Schänzer W.

Methods Mol Biol. 2019;1855:131-149. doi: 10.1007/978-1-4939-8793-1_14.

PMID:
30426415
17.

The 36th Manfred Donike workshop on doping analysis.

Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1633-1634. doi: 10.1002/dta.2536. Epub 2018 Nov 26. No abstract available.

PMID:
30394671
18.

Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes.

Knoop A, Thomas A, Thevis M.

Rapid Commun Mass Spectrom. 2019 Feb 28;33(4):371-380. doi: 10.1002/rcm.8337.

PMID:
30394592
19.

Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls.

Piper T, Dib J, Putz M, Fusshöller G, Pop V, Lagojda A, Kuehne D, Geyer H, Schänzer W, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1646-1656. doi: 10.1002/dta.2527. Epub 2018 Nov 18.

PMID:
30379415
20.

Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.

Nader E, Grau M, Fort R, Collins B, Cannas G, Gauthier A, Walpurgis K, Martin C, Bloch W, Poutrel S, Hot A, Renoux C, Thevis M, Joly P, Romana M, Guillot N, Connes P.

Nitric Oxide. 2018 Dec 1;81:28-35. doi: 10.1016/j.niox.2018.10.003. Epub 2018 Oct 19.

PMID:
30342855
21.

Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry.

Thomas A, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1761-1768. doi: 10.1002/dta.2518. Epub 2018 Nov 8.

PMID:
30298989
22.

Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS.

Walpurgis K, Thomas A, Lange T, Reichel C, Geyer H, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1714-1721. doi: 10.1002/dta.2513. Epub 2018 Oct 30.

PMID:
30285318
23.

Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance.

Hoffmeister T, Schwenke D, Krug O, Wachsmuth N, Geyer H, Thevis M, Byrnes WC, Schmidt WFJ.

Front Physiol. 2018 Sep 19;9:1289. doi: 10.3389/fphys.2018.01289. eCollection 2018.

24.

Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review.

Görgens C, Guddat S, Thomas A, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1755-1760. doi: 10.1002/dta.2503. Epub 2018 Nov 8.

PMID:
30239151
25.

Case Study: Atypical δ13 C values of urinary norandrosterone.

Hülsemann F, Gougoulidis V, Schertel T, Fusshöller G, Flenker U, Piper T, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1728-1733. doi: 10.1002/dta.2498. Epub 2018 Oct 25.

PMID:
30230253
26.

Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.

Gaunitz F, Lehmann S, Thomas A, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K.

Int J Legal Med. 2018 Nov;132(6):1645-1657. doi: 10.1007/s00414-018-1911-8. Epub 2018 Sep 15. Erratum in: Int J Legal Med. 2018 Dec 5;:.

PMID:
30219927
27.

Updated protocols for the detection of Sotatercept and Luspatercept in human serum.

Reichel C, Gmeiner G, Walpurgis K, Thevis M.

Drug Test Anal. 2018 Nov;10(11-12):1708-1713. doi: 10.1002/dta.2500. Epub 2018 Oct 1.

PMID:
30203930
28.

Response to letter to the editor: "Comments on Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone".

Forsdahl G, Geisendorfer T, Göschl L, Pfeffer S, Gärtner P, Thevis M, Gmeiner G.

Drug Test Anal. 2019 Jan;11(1):185. doi: 10.1002/dta.2486. Epub 2018 Sep 9. No abstract available.

PMID:
30133177
29.

Erythropoietic effects of low-dose cobalt application.

Hoffmeister T, Schwenke D, Wachsmuth N, Krug O, Thevis M, Byrnes WC, Schmidt WFJ.

Drug Test Anal. 2019 Feb;11(2):200-207. doi: 10.1002/dta.2478. Epub 2018 Sep 8.

PMID:
30110719
30.

Development and validation of a multidimensional gas chromatography/combustion/isotope ratio mass spectrometry-based test method for analyzing urinary steroids in doping controls.

Putz M, Piper T, Casilli A, Radler de Aquino Neto F, Pigozzo F, Thevis M.

Anal Chim Acta. 2018 Nov 7;1030:105-114. doi: 10.1016/j.aca.2018.05.016. Epub 2018 May 5.

PMID:
30032759
31.

Analysis of new growth promoting black market products.

Krug O, Thomas A, Malerød-Fjeld H, Dehnes Y, Laussmann T, Feldmann I, Sickmann A, Thevis M.

Growth Horm IGF Res. 2018 Aug;41:1-6. doi: 10.1016/j.ghir.2018.05.001. Epub 2018 May 19.

PMID:
29864719
32.

Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats.

Mori Y, Ko E, Furrer R, Qu LC, Wiber SC, Fantus IG, Thevis M, Medline A, Giacca A.

Endocr Connect. 2018 May;7(5):739-748. doi: 10.1530/EC-17-0358. Epub 2018 Apr 24.

33.

Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone.

Forsdahl G, Geisendorfer T, Göschl L, Pfeffer S, Gärtner P, Thevis M, Gmeiner G.

Drug Test Anal. 2018 Mar 23. doi: 10.1002/dta.2385. [Epub ahead of print]

PMID:
29570240
34.

Analytical challenges in sports drug testing.

Thevis M, Krug O, Geyer H, Walpurgis K, Baume N, Thomas A.

Anal Bioanal Chem. 2018 Mar;410(9):2275-2281. doi: 10.1007/s00216-018-0934-9. Epub 2018 Feb 14.

PMID:
29445832
35.

Equine in vivo-derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites.

Hansson A, Knych H, Stanley S, Berndtson E, Jackson L, Bondesson U, Thevis M, Hedeland M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:91-98. doi: 10.1016/j.jchromb.2017.12.010. Epub 2017 Dec 7.

PMID:
29334634
36.

Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.

Garg N, Hansson A, Knych HK, Stanley SD, Thevis M, Bondesson U, Hedeland M, Globisch D.

Org Biomol Chem. 2018 Jan 31;16(5):698-702. doi: 10.1039/c7ob03030d.

PMID:
29319101
37.

Growth hormone isoform-differential mass spectrometry for doping control purposes.

Arsene C, Schulze D, Röthke A, Thevis M, Henrion A.

Drug Test Anal. 2018 Jun;10(6):938-946. doi: 10.1002/dta.2350. Epub 2018 Feb 26.

PMID:
29278456
38.

Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation.

Thevis M, Volmer DA.

Eur J Mass Spectrom (Chichester). 2018 Feb;24(1):145-156. doi: 10.1177/1469066717731228. Epub 2017 Sep 13.

PMID:
29232975
39.

Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS.

Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M.

Proteomics Clin Appl. 2018 May;12(3):e1700120. doi: 10.1002/prca.201700120. Epub 2018 Jan 19.

PMID:
29226558
40.

Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blotting.

Reichel C, Farmer L, Gmeiner G, Walpurgis K, Thevis M.

Drug Test Anal. 2018 Jun;10(6):927-937. doi: 10.1002/dta.2346. Epub 2017 Dec 27.

PMID:
29193906
41.

Annual banned-substance review: Analytical approaches in human sports drug testing.

Thevis M, Kuuranne T, Geyer H.

Drug Test Anal. 2018 Jan;10(1):9-27. doi: 10.1002/dta.2336. Epub 2017 Dec 18. Review.

PMID:
29149502
42.

The 35th Manfred Donike workshop on doping analysis.

Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1657. doi: 10.1002/dta.2328. Epub 2017 Nov 17. No abstract available.

PMID:
29065248
43.

Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports.

Thomas A, Knoop A, Schänzer W, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1799-1803. doi: 10.1002/dta.2306. Epub 2017 Nov 13.

PMID:
28941172
44.

Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum.

Reichel C, Gmeiner G, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1721-1730. doi: 10.1002/dta.2302. Epub 2017 Nov 9.

PMID:
28929587
45.

Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry.

Lehmann S, Kieliba T, Beike J, Thevis M, Mercer-Chalmers-Bender K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 1;1064:124-138. doi: 10.1016/j.jchromb.2017.09.003. Epub 2017 Sep 7.

PMID:
28922649
46.

Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples.

Piper T, Thevis M.

Methods Enzymol. 2017;596:403-432. doi: 10.1016/bs.mie.2017.07.013. Epub 2017 Aug 24.

PMID:
28911778
47.

Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.

Forensic Sci Int. 2017 Oct;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. Epub 2017 Aug 26.

PMID:
28869822
48.

Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry.

Piper T, Putz M, Schänzer W, Pop V, McLeod MD, Uduwela DR, Stevenson BJ, Thevis M.

Drug Test Anal. 2017 Nov;9(11-12):1695-1703. doi: 10.1002/dta.2291. Epub 2017 Oct 27.

PMID:
28836353
49.

Carbon isotope ratios of endogenous steroids in Belgian Blue and Holstein cattle: Method development, reference population studies and application to steroid misuse control.

Piper T, Putz M, Delahaut P, Thevis M.

Rapid Commun Mass Spectrom. 2017 Nov 15;31(21):1793-1802. doi: 10.1002/rcm.7964.

PMID:
28833805
50.

Nutrition Status of Young Elite Female German Football Players.

Braun H, von Andrian-Werburg J, Schänzer W, Thevis M.

Pediatr Exerc Sci. 2018 Feb 1;30(1):157-167. doi: 10.1123/pes.2017-0072. Epub 2017 Oct 20.

PMID:
28787242

Supplemental Content

Loading ...
Support Center